Nonoperative Hip Fracture Management Practices and Patient Survival Compared to Surgical Care: an Analysis of Estonian Population-wide Data

Overview

Journal Arch Osteoporos

Publisher Springer

Date 2021 Jun 26

PMID 34173061

Citations 7

Authors

Part Prommik

Kaspar Tootsi

Toomas Saluse

Aare Martson

Helgi Kolk

Affiliations

Soon will be listed here.

Abstract

Purpose: Reasons underpinning hip fracture (HF) nonoperative management (NOM) are seldom analysed. This study aims to identify the reasons behind NOM and assess the accuracy of these decisions using these patients' survival compared with those treated with operative management (OM).

Methods: This is a retrospective cohort study based on population-wide administrative health data, including patients aged ≥ 50 with an index HF diagnosis between January 2009 and September 2017. NOM patients were subgrouped according to their expected prognoses, and their survival up to 36 months was compared with those treated surgically.

Results: From a total of 11,210 included patients, 6.8% (766) received NOM. Varying reasons lead to NOM, dividing them further into five distinct subgroups: (I) 46% NOM decision due to poor expected prognosis with OM; (II) 29% NOM decision due to poor expected prognosis for mixed reasons; (III) 15% NOM decision due to good expected prognosis with NOM; (IV) 8.0% NOM decision due to patient's refusal of OM; and (V) 1.3% NOM decision due to occult HF. Only poor prognosis and patients who refused OM (I, II, IV) had worse survival than OM patients. However, a relatively high proportion of the poor prognosis patients survived 1 year (29%).

Conclusion: Although there was high variability in reasons underpinning HF NOM, none of these practices conclusively outweigh OM's superiority. NOM should be considered with utmost care and only for patients for whom OM is out of the question - well-defined medical unfitness or carefully considered refusal by understanding the increased mortality risk.

Citing Articles

A Novel Triad of Bio-Inspired Design, Digital Fabrication, and Bio-Derived Materials for Personalised Bone Repair.

Dei Rossi G, Vergani L, Buccino F Materials (Basel). 2024; 17(21).

PMID: 39517582 PMC: 11547793. DOI: 10.3390/ma17215305.

Perioperative and Postoperative Outcomes of Proximal Hip Fracture: A Comparison of Orthopedic and Geriatric Care Models.

Lubovsky O, Rosinsky P, Artoul R, Avraham D, Oulianski M Cureus. 2024; 16(7):e65899.

PMID: 39219873 PMC: 11364812. DOI: 10.7759/cureus.65899.

Palliative Non-Operative Management in Geriatric Hip Fracture Patients: When Would Surgeons Abstain from Surgery?.

Bui M, Groothuis-Oudshoorn C, Witteveen A, Hegeman J J Clin Med. 2024; 13(6).

PMID: 38541820 PMC: 10971027. DOI: 10.3390/jcm13061594.

Characteristics and Outcomes of Nonoperatively Managed Patients With Hip Fracture Using the Dutch Hip Fracture Audit.

Bremen H, Seppala L, Hegeman J, Van der Velde N, Willems H J Orthop Trauma. 2024; 38(5):265-272.

PMID: 38259058 PMC: 11017835. DOI: 10.1097/BOT.0000000000002778.

Poor prognosis and risk factors of nonoperative treatment hip fracture patients with end-stage renal disease.

Zhan P, Lu Y, Wang L Medicine (Baltimore). 2024; 103(3):e36446.

PMID: 38241579 PMC: 10798693. DOI: 10.1097/MD.0000000000036446.

References

Moulton L, Green N, Sudahar T, Makwana N, Whittaker J . Outcome after conservatively managed intracapsular fractures of the femoral neck. Ann R Coll Surg Engl. 2015; 97(4):279-82. PMC: 4473865. DOI: 10.1308/003588415X14181254788809. View

van de Ree C, de Jongh M, Peeters C, de Munter L, Roukema J, Gosens T . Hip Fractures in Elderly People: Surgery or No Surgery? A Systematic Review and Meta-Analysis. Geriatr Orthop Surg Rehabil. 2017; 8(3):173-180. PMC: 5557195. DOI: 10.1177/2151458517713821. View

Ooi L, Wong T, Toh C, Wong H . Hip fractures in nonagenarians--a study on operative and non-operative management. Injury. 2004; 36(1):142-7. DOI: 10.1016/j.injury.2004.05.030. View

Parker M, Johansen A . Hip fracture. BMJ. 2006; 333(7557):27-30. PMC: 1488757. DOI: 10.1136/bmj.333.7557.27. View

Prommik P, Kolk H, Sarap P, Puuorg E, Harak E, Kukner A . Estonian hip fracture data from 2009 to 2017: high rates of non-operative management and high 1-year mortality. Acta Orthop. 2019; 90(2):159-164. PMC: 6461069. DOI: 10.1080/17453674.2018.1562816. View

Frenkel Rutenberg T, Vitenberg M, Haviv B, Velkes S . Timing of physiotherapy following fragility hip fracture: delays cost lives. Arch Orthop Trauma Surg. 2018; 138(11):1519-1524. DOI: 10.1007/s00402-018-3010-1. View

Cram P, Yan L, Bohm E, Kuzyk P, Lix L, Morin S . Trends in Operative and Nonoperative Hip Fracture Management 1990-2014: A Longitudinal Analysis of Manitoba Administrative Data. J Am Geriatr Soc. 2016; 65(1):27-34. DOI: 10.1111/jgs.14538. View

Johansen A, Golding D, Brent L, Close J, Gjertsen J, Holt G . Using national hip fracture registries and audit databases to develop an international perspective. Injury. 2017; 48(10):2174-2179. DOI: 10.1016/j.injury.2017.08.001. View

Jain R, Basinski A, Kreder H . Nonoperative treatment of hip fractures. Int Orthop. 2003; 27(1):11-7. PMC: 3673693. DOI: 10.1007/s00264-002-0404-y. View

10.

Penrod J, Litke A, Hawkes W, Magaziner J, Koval K, Doucette J . Heterogeneity in hip fracture patients: age, functional status, and comorbidity. J Am Geriatr Soc. 2007; 55(3):407-13. DOI: 10.1111/j.1532-5415.2007.01078.x. View

11.

Marufu T, Mannings A, Moppett I . Risk scoring models for predicting peri-operative morbidity and mortality in people with fragility hip fractures: Qualitative systematic review. Injury. 2015; 46(12):2325-34. DOI: 10.1016/j.injury.2015.10.025. View

12.

Brozek W, Reichardt B, Kimberger O, Zwerina J, Dimai H, Kritsch D . Mortality after hip fracture in Austria 2008-2011. Calcif Tissue Int. 2014; 95(3):257-66. DOI: 10.1007/s00223-014-9889-9. View

13.

Diamantopoulos A, Hoff M, Skoie I, Hochberg M, Haugeberg G . Short- and long-term mortality in males and females with fragility hip fracture in Norway. A population-based study. Clin Interv Aging. 2013; 8:817-23. PMC: 3704300. DOI: 10.2147/CIA.S45468. View

14.

Jurisson M, Vorobjov S, Kallikorm R, Lember M, Uuskula A . The incidence of hip fractures in Estonia, 2005-2012. Osteoporos Int. 2014; 26(1):77-84. DOI: 10.1007/s00198-014-2820-4. View

15.

Radley D, Gottlieb D, Fisher E, Tosteson A . Comorbidity risk-adjustment strategies are comparable among persons with hip fracture. J Clin Epidemiol. 2008; 61(6):580-7. PMC: 2653048. DOI: 10.1016/j.jclinepi.2007.08.001. View

16.

Toson B, Harvey L, Close J . The ICD-10 Charlson Comorbidity Index predicted mortality but not resource utilization following hip fracture. J Clin Epidemiol. 2014; 68(1):44-51. DOI: 10.1016/j.jclinepi.2014.09.017. View

17.

Quan H, Li B, Saunders L, Parsons G, Nilsson C, Alibhai A . Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database. Health Serv Res. 2008; 43(4):1424-41. PMC: 2517283. DOI: 10.1111/j.1475-6773.2007.00822.x. View

18.

Patel K, Kay R, Rowell L . Comparing proportional hazards and accelerated failure time models: an application in influenza. Pharm Stat. 2006; 5(3):213-24. DOI: 10.1002/pst.213. View

19.

Vochteloo A, van der Burg B, Mertens B, Niggebrugge A, de Vries M, Tuinebreijer W . Outcome in hip fracture patients related to anemia at admission and allogeneic blood transfusion: an analysis of 1262 surgically treated patients. BMC Musculoskelet Disord. 2011; 12:262. PMC: 3226448. DOI: 10.1186/1471-2474-12-262. View

20.

Hu F, Jiang C, Shen J, Tang P, Wang Y . Preoperative predictors for mortality following hip fracture surgery: a systematic review and meta-analysis. Injury. 2011; 43(6):676-85. DOI: 10.1016/j.injury.2011.05.017. View